We see research and development as a strategic area for the group.
We are pledged to manage knowledge and innovation to develop, in a systematic and sustained manner, internationally competitive therapeutic solutions that merit acceptance from the scientific community, regulatory authorities and the market and which, as a consequence deliver value to the Company and to its shareholders, employees, medical fraternity, consumers and other business partners.
This commitment will be fulfilled, throughout the Company, by adhering to the following principles:
• Organizing and running the RDI management system, so that its working groups produce ground-breaking ideas that can become projects that could generate value for the market.
• Ensuring proper planning, execution and control of projects and a judicious provision of resources in strict observance of and compliance with the regulatory, technical and normative requirements which apply to our business operations.
• Fostering the motivation, creativity and upskilling of employees so as to constantly promote a culture of rigour and an environment in which scientific and technological knowledge is generated.
• Continuously improving the effectiveness of the RDI management system, to maximize return on available resources and ensure the assessment and promotion of the results.